Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

Natalia Polanco, Elena Gutiérrez, Adelardo Covarsí, Francisco Ariza, Agustín Carreño, Ana Vigil, José Baltar, Gema Fernández-Fresnedo, Carmen Martín, Salvador Pons, Dolores Lorenzo, Carmen Bernis, Pilar Arrizabalaga, Gema Fernández-Juárez, Vicente Barrio, Milagros Sierra, Ines Castellanos, Mario Espinosa, Francisco Rivera, Aniana Oliet, Francisco Fernández-Vega, Manuel Praga, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología, Natalia Polanco, Elena Gutiérrez, Adelardo Covarsí, Francisco Ariza, Agustín Carreño, Ana Vigil, José Baltar, Gema Fernández-Fresnedo, Carmen Martín, Salvador Pons, Dolores Lorenzo, Carmen Bernis, Pilar Arrizabalaga, Gema Fernández-Juárez, Vicente Barrio, Milagros Sierra, Ines Castellanos, Mario Espinosa, Francisco Rivera, Aniana Oliet, Francisco Fernández-Vega, Manuel Praga, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología

Abstract

Spontaneous remission is a well known characteristic of idiopathic membranous nephropathy, but contemporary studies describing predictors of remission and long-term outcomes are lacking. We conducted a retrospective, multicenter cohort study of 328 patients with nephrotic syndrome resulting from idiopathic membranous nephropathy that initially received conservative therapy. Spontaneous remission occurred in 104 (32%) patients: proteinuria progressively declined after diagnosis until remission of disease at 14.7 +/- 11.4 months. Although spontaneous remission was more frequent with lower levels of baseline proteinuria, it also frequently occurred in patients with massive proteinuria: 26% among those with baseline proteinuria 8 to 12 g/24 h and 22% among those with proteinuria >12 g/24 h. Baseline serum creatinine and proteinuria, treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists, and a >50% decline of proteinuria from baseline during the first year of follow-up were significant independent predictors for spontaneous remission. Only six patients (5.7%) experienced a relapse of nephrotic syndrome. The incidence of death and ESRD were significantly lower among patients with spontaneous remission. In conclusion, spontaneous remission is common among patients with nephrotic syndrome resulting from membranous nephropathy and carries a favorable long-term outcome with a low incidence of relapse. A decrease in proteinuria >50% from baseline during the first year predicts spontaneous remission.

Figures

Figure 1.
Figure 1.
Evolution of proteinuria in patients with SR. The line within the box denotes the median and the box spans the interquartile range (25th to 75th percentiles).
Figure 2.
Figure 2.
Probability of SR in patients treated with ACEIs/ARBs and in patients who did not receive this treatment.
Figure 3.
Figure 3.
(A) Incidence of deaths and (B) renal survival in patients with or without SR.
Figure 4.
Figure 4.
Evolution of serum creatinine (lines) and proteinuria (box plots) in patients with baseline proteinuria >12 g/24 h for patients (A) with and (B) without SR. For proteinuria, the line within the box denotes the median and the box spans the interquartile range (25th to 75th percentiles).

Source: PubMed

3
Tilaa